Modulation of allergic responses by mitochondrial STAT3 inhibitors

Area of Science:

• Immunology
• Pharmacology
• Cell Biology

Background:

• Mast cell mitochondrial STAT3 is a novel target for regulating allergic responses.
• STAT3 plays a crucial role in immunologically mediated mast cell degranulation.

Purpose of the Study:

• To investigate the effects of two novel mitochondrial STAT3 inhibitors, Mitocur-1 and Mitocur-3, on allergic responses.
• To explore the mechanism by which these inhibitors modulate mast cell function.

Main Methods:

• In vitro studies using cultured human/mouse mast cells and rat basophilic leukemia (RBL) cells.
• In vivo studies using a mouse model of allergic asthma.
• Assessment of mast cell degranulation, cytokine secretion, OXPHOS activity, STAT3 phosphorylation, eosinophilia, neutrophilia, and histamine levels.

Main Results:

• Low concentrations of mitochondrial STAT3 inhibitors reduced mast cell exocytosis and cytokine release without affecting STAT3 target gene expression.
• Inhibition was linked to decreased OXPHOS activity and STAT3 serine 727 phosphorylation.
• One inhibitor significantly reduced allergic asthma symptoms, including eosinophilia, neutrophilia, and blood histamine levels in mice.

Conclusions:

• Mitochondrial STAT3 inhibitors effectively suppress mast cell degranulation and associated allergic responses.
• These findings support the development of mitochondrial STAT3 inhibitors as a potential therapeutic strategy for allergy-associated diseases.